血友病合并抑制物患者应用凝血酶原复合物序贯重组人凝血因子Ⅶa围术期治疗1例
雪雯 宋, 梦娟 李, 冰洁 丁, 烽迪 王, 俊霞 胡, 静 张, 虎 周 · 2024
Read 血友病合并抑制物患者应用凝血酶原复合物序贯重组人凝血因子Ⅶa围术期治疗1例 by 雪雯 宋, 梦娟 李, 冰洁 丁, 烽迪 王, 俊霞 胡, 静 张, 虎 周 (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13523885.txt.
Description
Clinicians in China report one case of major joint surgery in a man whose blood cannot clot in the normal way. Their 2024 case report, written in Chinese, follows a man in his early forties with severe hemophilia A. His body had also built blockers against the standard clotting factor, which made surgery far riskier. Years of joint bleeds had wrecked his knees, and he came in for a left knee replacement.
The team used two bypass drugs in sequence across the days around surgery. The operation finished with modest blood loss and no transfusion. A later bleed at the new joint was stopped by raising drug doses. Two years on, the man walks with a near-normal gait. The authors argue the paired sequence is safe and workable, while noting that dosing plans for such surgery still lack a shared standard.
Catalog record
| CREATOR | 雪雯 宋, 梦娟 李, 冰洁 丁, 烽迪 王, 俊霞 胡, 静 张, 虎 周 |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |